drugset / Trial / NCT01149746
Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The objective of this study is to evaluate the comparative bioavailability between Tamsulosin Hydrochloride 0.4 mg Capsules (Teva Pharmaceuticals USA) and Flomax® 0.4 mg Capsules (Boehringer Ingelheim Pharmaceuticals, Inc. USA), after a single-dose in healthy subjects under fasting conditions.
Timeline
- Start
- 2004-12
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |
Indications
No indication recorded.